InternationalUSRemember you can easily switch between MIP US and MIP International at any time

Brexit: UK pharma fears international IP exhaustion scheme

Charlotte Kilpatrick, London

Pharma in-house counsel say an international IP exhaustion framework could undercut the UK drugs market and create shortages in other parts of the world

exhaustion mainA post-Brexit international IP exhaustion scheme could create drug shortages and profit losses for pharmaceutical businesses, according to industry in-house sources in the UK.  

As a former EU member state, the UK historically benefited from parallel imports of...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null

null null null

November / December 2019

IP law: are the pressures taking their toll?

Following World Mental Health Day, Max Walters seeks the views of in-house professionals on whether they struggle with workplace pressures, and asks how to improve wellbeing

Most read articles